Ally Bridge Group »

Jasper Therapeuritc shares owned by Ally Bridge Group

Quarter-by-quarter ownership of Jasper Therapeuritc (JSPR) shares owned by Ally Bridge Group from 13F filings

Historical chart of Ally Bridge Group investment in Jasper Therapeuritc

Tip: Access up to 7 years of quarterly data

All positions including Jasper Therapeuritc held by Ally Bridge Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Jasper Therapeuritc by Ally Bridge Group

Quarter filed Position value Share count Share price at filing
2024-03-31 $8.5M 290k 29.36

More positions owned by Ally Bridge Group

Blueprint Medicines (BPMC)
Soleno Therapeutics (SLNO)
Cg Oncology
Xenon Pharmaceuticals (XENE)
Verona Pharma Sponsored Ads (VRNA)
Merus N V (MRUS)
Praxis Precision Medicines I (PRAX)
Mind Medicine Mindmed Com New (MNMD)
Avadel Pharmaceuticals Sponsored Adr (AVDL)
Geron Corporation (GERN)
Jasper Therapeutics Com New (JSPR)
Kura Oncology (KURA)
Insmed Com Par $.01 (INSM)
Dianthus Therapeutics (DNTH)
Olema Pharmaceuticals (OLMA)

View all positions for Ally Bridge Group

Top funds holding Jasper Therapeuritc

Velan Capital Investment Management
Soleus Capital Management
Carlyle
Qiming U.S. Ventures Management
Avidity Partners Management
Franklin Resources
Vanguard Group
Samsara BioCapital
Sphera Funds Management
Octagon Capital Advisors
Kingdon Capital Management
Opaleye Management
Dr. Jeffrey R. Jay, M.D.
Rock Springs Capital Management
Woodline Partners

View all funds holding Jasper Therapeuritc